Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects
- PMID: 1664256
- DOI: 10.1021/tx00020a008
Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects
Abstract
The role of human cytochrome P-450 IIE1 (P-450 IIE1) in the oxidation of a number of suspect carcinogens was examined by using a variety of approaches, including (1) selective inhibition of catalytic activity in human liver microsomes by diethyldithiocarbamate, which was found to be a selective mechanism-based inactivator of P-450 IIE1, (2) correlation of rates of different catalytic activities with each other and with chlorzoxazone 6-hydroxylation, an indicator of P-450 IIE1, in human liver microsomes, (3) demonstration of catalytic activity in reconstituted systems containing purified human P-450 IIE1, and (4) immunoinhibition of catalytic activity in human liver microsomes with rabbit anti-human P-450 IIE1. The results collectively indicate that P-450 IIE1 is a major catalyst of the oxidation of benzene, styrene, CCl4, CHCl3, CH2Cl2, CH3Cl, CH3CCl3, 1,2-dichloropropane, ethylene dichloride, ethylene dibromide, vinyl chloride, vinyl bromide, acrylonitrile, vinyl carbamate, ethyl carbamate, and trichloroethylene. Levels of P-450 IIE1 can vary considerably among individual humans--the availability of chlorzoxazone as a noninvasive probe of human P-450 IIE1 and of disulfiram (oxidized diethyldithiocarbamate) as an inhibitor may facilitate discernment of the in vivo significance of human P-450 IIE1 as a factor in the bioactivation and detoxication of these cancer suspects. Further, many investigations with diethyldithiocarbamate, disulfiram, and ethanol in humans and experimental animals may be interpreted in light of mechanisms involving P-450 IIE1.
Similar articles
-
Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1.Chem Res Toxicol. 1990 Nov-Dec;3(6):566-73. doi: 10.1021/tx00018a012. Chem Res Toxicol. 1990. PMID: 2103328
-
Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1.Mol Pharmacol. 1992 Jan;41(1):76-82. Mol Pharmacol. 1992. PMID: 1370708
-
Epoxidation of acrylonitrile by rat and human cytochromes P450.Chem Res Toxicol. 1993 Nov-Dec;6(6):866-71. doi: 10.1021/tx00036a017. Chem Res Toxicol. 1993. PMID: 8117926
-
Hepatocyte cytotoxicity induced by various hepatotoxins mediated by cytochrome P-450IIE1: protection with diethyldithiocarbamate administration.Chem Biol Interact. 1992 Feb;81(3):271-89. doi: 10.1016/0009-2797(92)90082-v. Chem Biol Interact. 1992. PMID: 1311644
-
Oxidative and reductive metabolism by cytochrome P450 2E1.FASEB J. 1992 Jan 6;6(2):724-30. doi: 10.1096/fasebj.6.2.1537462. FASEB J. 1992. PMID: 1537462 Review.
Cited by
-
Albumin infusion ameliorates liver injury in streptozotocin-induced diabetic rats.Vet Med (Praha). 2022 Mar 6;67(5):245-256. doi: 10.17221/14/2021-VETMED. eCollection 2022 May. Vet Med (Praha). 2022. PMID: 39170903 Free PMC article.
-
CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.PLoS One. 2012;7(11):e48265. doi: 10.1371/journal.pone.0048265. Epub 2012 Nov 5. PLoS One. 2012. PMID: 23139769 Free PMC article.
-
Associations between CYP1A1 rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies.Oncotarget. 2016 Aug 9;7(32):51365-51374. doi: 10.18632/oncotarget.10331. Oncotarget. 2016. PMID: 27384991 Free PMC article.
-
Drug interactions with tobacco smoking. An update.Clin Pharmacokinet. 1999 Jun;36(6):425-38. doi: 10.2165/00003088-199936060-00004. Clin Pharmacokinet. 1999. PMID: 10427467 Review.
-
Hepatotoxic interaction between carbon tetrachloride and chloroform in ethanol treated rats.Arch Toxicol. 1992;66(8):580-6. doi: 10.1007/BF01973389. Arch Toxicol. 1992. PMID: 1463393
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases